Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Janssen
 More »

  • Biotechs Need to Walk the Walk on Drug Value
    In June 2012, Massachusetts joined with Abbott, Biogen Idec, EMD Serono, Janssen, Merck & ... AZ, BMS, Eli Lilly, Gilead, Glaxo, Janssen, Merck, Mitsubishi Tanabe, Novartis, ...
    5-15-2013
  • Companion Diagnostics: 52 Pick-Up
    ... Metamark Genetics and Johnson & Johnson (Janssen Biotech) Agreement announced December 19, ... Upon selection of targets, Janssen will receive a limited exclusive license and take ...
    5-9-2013
  • TSRI, Janssen Team Up on Infectious Disease Research
    The Scripps Research Institute (TSRI) and Janssen Pharmaceuticals are collaborating on ... Under the terms of this five-year agreement, Janssen is entitled to certain license ...
    5-7-2013
  • Another Alzheimer's Drug Fails Phase III Trial
    ... However, Lilly said in December it plans to launch by Q3 a new Phase III study of the drug in patients with mild Alzheimer's. Also last year, Johnson & Johnson's Janssen Alzheimer ...
    5-7-2013
  • Ascletis Obtains Chinese Rights to Janssen HIV Treatment
    China and Macau. Johnson & Johnson's Janssen subsidiary will retain all rights in the ... Wu said. Three clinical studies completed by Janssen, including a Phase IIa study, showed ...
    4-30-2013
  • Hormone Holds Promise for Replacing Insulin Injections
    University and Johnson & Johnson's Janssen Pharmaceuticals subsidiary has discovered ... 2011, then sublicensed to Janssen in July 2012, when it joined the CureBeta collaboration. ...
    4-26-2013
  • GEN | Biolinks
    ... - Assobiotec James Madison University Jamestown Community College Janssen Biotech, Inc. Janssen Research & Development, LLC Janssen, LP Japan Bioindustry Association ...
  • E&Y: Biotechs Must Walk the Walk on Drug Value
    In June 2012, Massachusetts joined with Abbott, Biogen Idec, EMD Serono, Janssen, Merck & ... AZ, BMS, Eli Lilly, Gilead, Glaxo, Janssen, Merck, Mitsubishi Tanabe, Novartis , ...
    4-22-2013
  • Alzheimer's: Lilly Investment Signals R&D Shift
    ... for Dementia (DAD), in Phase III studies of patients who are not ApoE4 noncarriers (Study 301) and patients who are (Study 302), led by J&J's Janssen Alzheimer Immunotherapy. ...
    4-17-2013
  • Pharmacyclics Achieves Another $50M Milestone
    its fifth patient, subsequently triggering a fourth $50 million milestone payment obligation from Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. ...
    4-11-2013
  • Myeloma Collaboration Unites Janssen, U.K. Institutions
    with Johnson & Johnson unit Janssen Biotech on research they hope will result in a potential new multiple myeloma drug. CRUK and Janssen will together fund up to 25 ...
    3-21-2013
  • A Good Day for Milestones
    ... In addition to this alliance with Ono, Receptos has completed a partnership with Janssen Pharmaceuticals and a collaboration with Eli Lilly . Two firms report receiving milestones ...
    3-7-2013
  • Janssen Teams Up with Araxes to Tackle Cancer Target
    Janssen Biotech is partnering with newcomer Araxes Pharma to develop therapeutics against ... Thereafter, Janssen Biotech will have sole responsibility for the continued development ...
    2-27-2013
  • "Bad Bugs" Projects Launched by IMI
    giants-AstraZeneca, GlaxoSmithKline, and Janssen Infectious Diseases Diagnostics-as well ... TRANSLOCATION involves five pharma companies-AZ, Glaxo, and Janssen, as well as Basilea ...
    2-11-2013
  • Consortium Launches €196M Drug Discovery "Factory"
    Merck and the other six pharmas-AstraZeneca, Bayer, Johnson & Johnson-owned Janssen Pharmaceutica, Lundbeck, Sanofi, and UCB Pharma-will contribute "at least" 300,000 chemical ...
    2-7-2013

  • Journal Articles

  • The Scientific Observatories on Mont Blanc
    Jean-Paul Richalet
    High Altitude Medicine & Biology
    While Jules Janssen and Xaver Imfeld were preparing the construction of the new observatory on the top of Mont Blanc, Dr. Jacottet died in 1891 at the Observatoire Vallot from a ...
  • Efficacy of Arnica montana D4 for Healing of Wounds After Hallux...
    Jens-Hagen Karow, Hans-Peter Abt, Markus Fröhling, Hanns Ackermann
    Journal of Alternative and Complementary Medicine, The
    No significant differences were found regarding the use of additional analgesics during the 4 postoperative days (Dipidolor,® Janssen-Cilag, Neuss, Germany; p = 0.54; Tramal,® ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll